Product

Hyperpolarized 129Xe

1 clinical trial

3 indications

Clinical trial
Defining a Noninvasive Signature for Pulmonary Vascular Remodeling in Group 3 PH
Status: Recruiting, Estimated PCD: 2024-12-30